)
)
)
TLC BioSciences
- Cutting-edge proprietary lipid-based nanoparticle (LNP) technology designed to enhance efficacy by enabling controlled, sustained drug release and precise targeted therapy
- Highly efficient and scalable manufacturing systems enhance the delivery of both established medicines and innovative therapies such as gene therapy, including CAR-T and mRNA treatments
- A robust pipeline extending well beyond R&D, featuring two assets currently in Phase 3 trials in the US and one already available on the market
- Portfolio targets critical unmet medical needs with significant market potential, focused on multiple therapeutic areas to enhance clinical and commercial growth
- Visionary founder and experienced management and advisor teams driving a clear and actionable roadmap for enduring success
Address
South San FranciscoUnited States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)